Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/183808
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Simple Summary: Emerging evidence points to succinate as an important oncometabolite in cancer development; however, the contribution of the succinate-SUCNR1 axis to cancer progression remains unclear. Head and neck squamous cell carcinoma (HNSCC) is associated with disease and treatmentrelated morbidity so there is an urgent need for innovation in treatment and diagnosis practices. Our aim was to evaluate the potential of the succinate-related pathway as a diagnostic and prognostic biomarker in HNSCC. The circulating succinate levels are increased in HNSCC, being a potential noninvasive biomarker for HNSCC diagnosis. Moreover, the succinate receptor (SUCNR1) and genes related to succinate metabolism, which are predominantly expressed in the tumoral mucosa as compared with healthy tissue, are positively associated with plasma succinate. Remarkably, we found that SUCNR1 and SDHA expression levels predict prognosis.
Matèries
Matèries (anglès)
Citació
Citació
TERRA, Ximena, CEPERUELO MALLAFRÉ, Victoria, MERMA, Carla, BENAIGES, Ester, BOSCH, Ramon, CASTILLO, Paola, FLORES, Joan carles, LEON, Xavier, VALDUVIECO, Izaskun, BASTE, Neus, CAMARA, Marina, LEJEUNE, Marylene, GUMA, Josep, VENDRELL, Joan, VILASECA, Isabel, FERNANDEZ VELEDO, Sonia, AVILÉS JURADO, Francesc xavier. Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker. _Cancers_. 2021. Vol. vol 13, núm. num 7, pàgs. 1-16. [consulta: 22 de febrer de 2026]. ISSN: 2072-6694. [Disponible a: https://hdl.handle.net/2445/183808]